passlisted in Coinbase#9 by calls of 844 on this host
0.005 USDC
per call, as the listing declares it on eip155:
- Validation state
- pass
- Uptime, 7 / 30 / 90 days
- 100% / 100% / 100%
- Calls, trailing 30 days
- 2
- Unique payers, trailing 30 days
- 1
- Last called
- 2026-09-28 13:54 UTC
- First observed by TOLLderived
- 2026-09-28
- Pricederived
- 0.005 USDC
- Networks
- 1
How big is this endpoint among the ones like it?
No trace is drawn of this endpoint’s own volume. Its counters have changed 1 time across 9 observations, and 3 changes are the fewest this site will draw a trace through, because two points and a guess are not a series. Every observation is in the JSON.
TOLL's first observation of calc leibovich 2018 was 2026-09-28.
calc leibovich 2018, a POST endpoint on api.magentlab.com, appears in the Coinbase registry; TOLL's taxonomy puts it in inference.
On Base, calc leibovich 2018 asks 0.005 USDC per call.
Callers of calc leibovich 2018 supply a JSON body with the field items.
calc leibovich 2018 answered the sweep of 2026-09-30 with a valid 402, as at every sweep since 2026-09-28.
A response from calc leibovich 2018, as declared, includes path, count and items.
Of api.magentlab.com's 844 listings, calc leibovich 2018 ranks tied 9th by calls with 248 others.
Over 30 days: 2 calls, one payer.
The last call to calc leibovich 2018 came 3 days before the snapshot, 2026-09-28.
Closest in price to calc leibovich 2018 within inference: llm at api.losbeto.xyz and prompt injection detect at agent.pocket.network.
calc leibovich 2018 is priced above 20% of comparable listings in inference.
Its payee wallet receives for 844 listed endpoints on one host.
The seller's tags on calc leibovich 2018 are leibovich-2018, rcc, kidney and prognosis.
256 other listings in inference declare exactly the same price.
the payment options, as of 2026-10-01 05:50 UTC · method · pinnable
| registry | network | asset | amount | scheme | pay to |
|---|---|---|---|---|---|
| Coinbase | eip155: | USDC | 0.005 USDC | exact | 0x836Be2…c19Ee2 |
the checks, as of 2026-09-30 08:52 UTC · method · pinnableendpoint answered HTTP 402
No named check failed.
Every sweep that observed this endpoint, newest first.
| observed, UTC | state | failed checks | sweep |
|---|---|---|---|
| 2026-09-30 08:52 UTC | pass | 0 | daily-2026-09-30 |
| 2026-09-29 20:57 UTC | pass | 0 | daily-2026-09-29 |
| 2026-09-28 16:48 UTC | pass | 0 | new-after-daily-2026-09-28 |
Presence in a registry, not liveness of the service (method). Newest first.
- listed in Coinbase
From the registry record, not validated by TOLL.the declared schema, as of 2026-09-28 13:54 UTC · method · live
The input and output block
{
"input": {
"body": {
"items": [
{
"n_stage": "n0",
"t_stage": "t1a",
"necrosis": false,
"histology": "clear_cell",
"nuclear_grade": 2,
"tumor_size_cm": 3
},
{
"n_stage": "n0",
"t_stage": "t1a",
"necrosis": false,
"histology": "clear_cell",
"nuclear_grade": 2,
"tumor_size_cm": 3
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/leibovich_2018",
"count": 2,
"items": [
{
"risk": "low",
"score": 0,
"formula": "leibovich_2018",
"n_stage": "n0",
"t_stage": "t1a",
"citation": {
"id": "leibovich-2018",
"doi": "10.1016/j.eururo.2018.01.005",
"pmid": "29398265",
"title": "Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery",
"source": "Eur Urol. 2018;73(5):772-780",
"authors": "Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP"
},
"necrosis": false,
"histology": "clear_cell",
"max_score": 12,
"components": [
{
"value": "t1a",
"factor": "t_stage",
"points": 0,
"present": true
},
{
"value": "n0",
"factor": "n_stage",
"points": 0,
"present": true
},
{
"value": 3,
"factor": "tumor_size_cm",
"points": 0,
"present": false
},
{
"value": 2,
"factor": "nuclear_grade",
"points": 0,
"present": true
},
{
"factor": "necrosis",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"nuclear_grade": 2,
"tumor_size_cm": 3,
"formula_expression": "ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model."
},
{
"risk": "low",
"score": 0,
"formula": "leibovich_2018",
"n_stage": "n0",
"t_stage": "t1a",
"citation": {
"id": "leibovich-2018",
"doi": "10.1016/j.eururo.2018.01.005",
"pmid": "29398265",
"title": "Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery",
"source": "Eur Urol. 2018;73(5):772-780",
"authors": "Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP"
},
"necrosis": false,
"histology": "clear_cell",
"max_score": 12,
"components": [
{
"value": "t1a",
"factor": "t_stage",
"points": 0,
"present": true
},
{
"value": "n0",
"factor": "n_stage",
"points": 0,
"present": true
},
{
"value": 3,
"factor": "tumor_size_cm",
"points": 0,
"present": false
},
{
"value": 2,
"factor": "nuclear_grade",
"points": 0,
"present": true
},
{
"factor": "necrosis",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"nuclear_grade": 2,
"tumor_size_cm": 3,
"formula_expression": "ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model."
}
]
}
}
}Cite this page
The pinned URL below renders this page from the snapshot of 2026-10-01 05:50 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).
Plain text
TOLL, "calc leibovich 2018 on api.magentlab.com", snapshot of 2026-10-01 05:50 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-leibovich-2018-ca8ec2/at/2026-10-01T05-50Z. Accessed [access date].
BibTeX
@misc{toll-e-api-magentlab-com-api-calc-leibovich-2018-ca8ec2-2026-10-01T05-50Z,
author = {TOLL},
title = {calc leibovich 2018 on api.magentlab.com},
howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-leibovich-2018-ca8ec2/at/2026-10-01T05-50Z}},
year = {2026},
month = {10},
note = {Pinned view of the snapshot of 2026-10-01 05:50 UTC. Accessed [access date].}
}None yet. Anything submitted through the form below is published here with its outcome.